Background: The Koebner phenomenon (KP) is a common entity observed in dermatological disorders. The reported incidence of KP in vitiligo varies widely. Although the KP is frequently observed in patients with viltiligo, the associated factors with KP has not been established yet. Objective: The aim is to estimate the prevalence of KP in vitiligo patients and to investigate the associated factors with KP among vitiligo characteristics. Methods: A cross-sectional observational study was conducted using 381 vitiligo patients. Demographic and clinical information was obtained via the completion of Vitiligo European Task Force (VETF) questionnaires. Patients with positive history of KP were extracted from this vitiligo database. Multivariate analysis was performed to assess associations with KP. Results: The median age of cases was 24 years (range, 0.6∼76). In total, 237 of the patients were male (62.2%). Vitiligo vulgaris was the most common type observed (152/381, 39.9%). Seventy-two percent (274/381) patients did not exhibit KP, whereas 28.1% (107/381) of patients exhibited this condition. Multivariable analysis showed the following to be independent factors with KP in patients with vitiligo: the progressive disease (odds ratio [OR] 
INTRODUCTION
Vitiligo is a disease that causes loss of skin pigmentation wherein epidermal melanocytes lose their function. The incidence of vitiligo worldwide is approximately 0.5% to 4% 1 .
Lesions at physical injury areas in normal/unaffected skin of patients with cutaneous diseases are referred to as Koebner phenomenon (KP) 2 . KP is the well-known phenomenon in dermatology 3 . However, its pathogenesis has not been elucidated to date 2 . KP is recognized in many diseases, such as vitiligo, lichen planus, psoriasis, and Darier's disease 2, 3 . The prevalence of KP in vitiligo differs widely, and it is reported to occur in 21% to 62% of patients 4 .
Clear evidence regarding the pathophysiology and clinical consequences of KP in vitiligo is sparse. We aimed to study the prevalence of KP in our vitiligo patients. Moreover, we sought to observe different associations with this response and to find out whether KP is associated with dis- Multivariate analysis was performed to assess various associations, such as total body surface area (BSA), status of disease progression, family history of vitiligo, presence of halo nevus, leucotrichia and other diseases associated with KP. Official approval was obtained from King Khalid University Hospital's Ethical Committee (E-16-2189).
Statistical analysis
The data was entered and analyzed using IBM SPSS Statistics ver. 22.0 (IBM Co., Armonk, NY, USA). Median+inter-quartile range (IQR) is provided for quantitative variables. Frequencies and percentages were obtained for qualitative variables. The Mann Whitney U test was applied to compare median differences among groups. Data normality was assessed using the Shapiro Wilk test. The Pearson chi-square and Fisher's exact tests were applied to observe associations between qualitative variables. Binary logistic regression analyses was also performed to observe the odds ratios (ORs) in various study parameters. A p-value of ＜0.05 was considered statistically significant.
RESULTS
A total of 381 cases of vitiligo were included in this study. Descriptive statistics are provided in Table 1 . The median 
DISCUSSION
The KP is a renowned phenomenon in dermatology. This condition is defined as "the development of lesions at sites of distinctively traumatized uninvolved skin of patients with cutaneous diseases." 2, 6 KP occurs in 21% to 62% of patients with vitiligo 3, 4, 7 . The clinical importance of KP is still not absolutely understood; however, a positive Koebner reaction could be a predictor of subsequent disease activity 7, 8 . Only limited data have been published to support this hypothesis 8 .
To date, the exact etiopathogenesis of KP in vitiligo remains unknown; however, multiple mechanisms, including immunological, neural and vascular factors that ultimately lead to depigmentation, are suggested 9 .
The concept of KP as a sign of more active or extensive vitiligo or as a risk factor of a reduced therapeutic response remains vague. In this study, the clinical profile of vitiligo patients with KP was compared with patients without KP. To our understanding, this comparison has not been described in the Arab population to date. Several significant differences were observed between patients with or without signs of KP, thus potentially providing guidelines for answering patients' questions with regard to prognosis and treatment response. In a previous study 5 , a history of KP was apparent in 30.4% of 217 patients of the VETF paper based on the question: 'Is there any depigmentation on scars (Koebner phenomenon)?' 5 Using the same question, our study revealed that KP was present in 107/381 (28.1%) of patients.
In an Indian study 10 , patients with KP exhibited a notably older age of onset and a reduced duration of illness. Of 1,416 patients studied, 94 (6.6%) had KP. Of these, 80 (85.1%) had NSV, and 8 (8.5%) had SV. Thus, KP was observed in 7.1% of patients with NSV and 7.8% of patients with SV. Patients exhibiting KP had a drastically older age at onset of vitiligo (17.7±15.0 years vs. 14.47±14.11 years; p＜0.01) and a reduced illness duration (6.49±7.45 years vs. 8.69±10.07 years; p=0.02) compared with those without KP. KP was significantly associated with the primary site of involvement, with legs being the most common site (28.9% of patients) followed by the face (20%) and hands (15.6%) (p＜0.001, v2 test) possibly because these sites are more at risk of trauma. In contrast, patients with KP in our study had a longer duration of illness but an older age of onset.
Our results indicate that males more frequently exhibit KP 64/107 (59.8%) than females 43 (40.2%). However, no significant difference between gender and KP was noted (Table 2) . In contrast, a study concluded that women are more prone to have KP (KP1 and KP2A) than men 8 . The same study suggested that the affected BSA was significantly increased in the presence of any KP subtype (p=0.038) 8 . Our results supported the previous findings that patients with KP also demonstrated an increased affected BSA (OR, 1.83; p=0.016); however, in contrast to our study, this study did not classify BSA as ＞2% and ≤2% (Table 3) . Interestingly, leukotrichia was more frequently observed in our patients without KP manifestation (p=0.044), for which the pathological link should be explored in future studies. In the present study, the group manifesting KP had a significantly higher median age compared with those without KP which is not reported before. But here we did not find any association of KP with early age of onset. This is in contrast to previous reports which tend to occurred more in early age of onset of disease 3 . One possibility involves the genetic differences between the two populations.
Other differences include the lack of association between the presence of KP and its diverse subtypes. Additionally, factors, such as atopy and autoimmune diseases, could be implicated. This difference might be attributed to the generally low frequency of disease associations in our study cohort, which in turn could be to a certain extent ascribed to the fact that the diagnosis of KP in our study was ex-clusively based on history. The observed differences between vitiligo patients with KP and vitiligo patients without KP indicates possible underlying differences in disease activity status. Patients with KP more likely have active vitiligo and are more prone to develop further depigmentation despite treatment. These clinically based associations should be confirmed by larger epidemiological and pathological studies to better understand the etiopathogenesis of and therapeutic options for vitiligo.
In conclusion, this study reveals a direct relation between KP and other clinical signs of vitiligo, such as BSA, duration of disease, and disease activity, among others. The scarcity of local literature regarding KP is an opportunity for prospective research with a proposed redefinition of KP in vitiligo as outlined via the consensus of the VETF group. Future studies involving larger numbers of patients will help to further explain the clinical characteristics of KP.
